Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol. [electronic resource]
Producer: 20040706Description: 171-7 p. digitalISSN:- 1397-3142
- Adolescent
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Area Under Curve
- Child
- Child, Preschool
- Daclizumab
- Drug Monitoring
- Female
- Follow-Up Studies
- Graft Rejection -- etiology
- Half-Life
- Humans
- IMP Dehydrogenase -- antagonists & inhibitors
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- pharmacokinetics
- Infant
- Kidney Transplantation
- Male
- Mycophenolic Acid -- analogs & derivatives
- Neutropenia -- chemically induced
- Prednisone -- therapeutic use
- Receptors, Interleukin-2 -- immunology
- Sirolimus -- pharmacokinetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.